Skip to main content
. 2013 Jul 16;8(7):e68154. doi: 10.1371/journal.pone.0068154

Figure 9. NTT-MMP-2 transgenic hearts exhibit enhanced injury following ex vivo ischemic-reperfusion injury.

Figure 9

Isolated hearts were subjected to ex vivo ischemia/reperfusion injury (30 min/30 min) as detailed in Materials and Methods. Left ventricular developed pressure (LVDP) and infarct size were measured as detailed in Materials and Methds. Recovered LVDP, expressed as the per cent of baseline LVDP, was significantly reduced in the NTT-MMP-2 transgenic hearts. Infarction size was increased by nearly 50% in the transgenic hearts. (nā€Š=ā€Š5ā€“6 for each study group; * P<0.05).